18.7 USD
-0.6 (-3.11%)
18.7 USD
0 (0%)
Overall NRC gets a fundamental rating of 4 out of 10. We evaluated NRC against 102 industry peers in the Health Care Providers & Services industry. NRC scores excellent on profitability, but there are concerns on its financial health. NRC does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year NRC was profitable.
NRC had a positive operating cash flow in the past year.
Each year in the past 5 years NRC has been profitable.
Each year in the past 5 years NRC had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 12.06%, NRC belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
NRC has a Return On Equity of 114.31%. This is amongst the best in the industry. NRC outperforms 99.02% of its industry peers.
The Return On Invested Capital of NRC (23.31%) is better than 96.08% of its industry peers.
NRC had an Average Return On Invested Capital over the past 3 years of 37.15%. This is significantly above the industry average of 9.61%.
The last Return On Invested Capital (23.31%) for NRC is well below the 3 year average (37.15%), which needs to be investigated, but indicates that NRC had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.06% | ||
| ROE | 114.31% | ||
| ROIC | 23.31% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
1.3 Margins
The Profit Margin of NRC (11.76%) is better than 98.04% of its industry peers.
In the last couple of years the Profit Margin of NRC has declined.
With an excellent Operating Margin value of 21.24%, NRC belongs to the best of the industry, outperforming 96.08% of the companies in the same industry.
In the last couple of years the Operating Margin of NRC has declined.
NRC has a Gross Margin of 62.05%. This is amongst the best in the industry. NRC outperforms 82.35% of its industry peers.
NRC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.24% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% |
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NRC is creating value.
The number of shares outstanding for NRC has been reduced compared to 1 year ago.
The number of shares outstanding for NRC has been reduced compared to 5 years ago.
The debt/assets ratio for NRC is higher compared to a year ago.
2.2 Solvency
NRC has an Altman-Z score of 3.52. This indicates that NRC is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NRC (3.52) is better than 71.57% of its industry peers.
NRC has a debt to FCF ratio of 6.89. This is a slightly negative value and a sign of low solvency as NRC would need 6.89 years to pay back of all of its debts.
NRC has a Debt to FCF ratio (6.89) which is comparable to the rest of the industry.
A Debt/Equity ratio of 5.31 is on the high side and indicates that NRC has dependencies on debt financing.
With a Debt to Equity ratio value of 5.31, NRC is not doing good in the industry: 79.41% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.31 | ||
| Debt/FCF | 6.89 | ||
| Altman-Z | 3.52 |
ROIC/WACC2.67
WACC8.74%
2.3 Liquidity
A Current Ratio of 0.53 indicates that NRC may have some problems paying its short term obligations.
With a Current ratio value of 0.53, NRC is not doing good in the industry: 86.27% of the companies in the same industry are doing better.
NRC has a Quick Ratio of 0.53. This is a bad value and indicates that NRC is not financially healthy enough and could expect problems in meeting its short term obligations.
NRC has a worse Quick ratio (0.53) than 84.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 |
3. Growth
3.1 Past
The earnings per share for NRC have decreased strongly by -36.45% in the last year.
Measured over the past years, NRC shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.70% on average per year.
Looking at the last year, NRC shows a decrease in Revenue. The Revenue has decreased by -3.50% in the last year.
NRC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.25% yearly.
EPS 1Y (TTM)-36.45%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-22.25%
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-3.38%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 26.34, NRC can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of NRC indicates a somewhat cheap valuation: NRC is cheaper than 61.76% of the companies listed in the same industry.
NRC's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.34 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NRC indicates a somewhat cheap valuation: NRC is cheaper than 63.73% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as NRC.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.46 | ||
| EV/EBITDA | 13.73 |
4.3 Compensation for Growth
The excellent profitability rating of NRC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NRC has a Yearly Dividend Yield of 3.32%.
Compared to an average industry Dividend Yield of 0.58, NRC pays a better dividend. On top of this NRC pays more dividend than 97.06% of the companies listed in the same industry.
NRC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.32% |
5.2 History
The dividend of NRC decreases each year by -17.40%.
NRC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-17.4%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
NRC pays out 67.82% of its income as dividend. This is not a sustainable payout ratio.
NRC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP67.82%
EPS Next 2YN/A
EPS Next 3YN/A
18.7
-0.6 (-3.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners49.7%
Inst Owner Change-4.53%
Ins Owners10.44%
Ins Owner Change2.62%
Market Cap423.74M
Revenue(TTM)139.10M
Net Income(TTM)16.36M
Analysts45
Price TargetN/A
Short Float %3.65%
Short Ratio4.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.32% |
Yearly Dividend0.48
Dividend Growth(5Y)-17.4%
DP67.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.34 | ||
| Fwd PE | N/A | ||
| P/S | 3.05 | ||
| P/FCF | 36.46 | ||
| P/OCF | 16.52 | ||
| P/B | 29.6 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.73 |
EPS(TTM)0.71
EY3.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.51
FCFY2.74%
OCF(TTM)1.13
OCFY6.05%
SpS6.14
BVpS0.63
TBVpS-2.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.18
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.06% | ||
| ROE | 114.31% | ||
| ROCE | 30.4% | ||
| ROIC | 23.31% | ||
| ROICexc | 23.85% | ||
| ROICexgc | 85.58% | ||
| OM | 21.24% | ||
| PM (TTM) | 11.76% | ||
| GM | 62.05% | ||
| FCFM | 8.35% |
ROA(3y)22.78%
ROA(5y)24%
ROE(3y)62.21%
ROE(5y)57.67%
ROIC(3y)37.15%
ROIC(5y)35.26%
ROICexc(3y)44.09%
ROICexc(5y)48.46%
ROICexgc(3y)273.96%
ROICexgc(5y)N/A
ROCE(3y)48.46%
ROCE(5y)46%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.97%
ROICexc growth 5Y-12.09%
OM growth 3Y-10.18%
OM growth 5Y-5.95%
PM growth 3Y-11.83%
PM growth 5Y-7.25%
GM growth 3Y-2.32%
GM growth 5Y-1.11%
F-Score6
Asset Turnover1.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.31 | ||
| Debt/FCF | 6.89 | ||
| Debt/EBITDA | 2.08 | ||
| Cap/Depr | 200.56% | ||
| Cap/Sales | 10.09% | ||
| Interest Coverage | 7.64 | ||
| Cash Conversion | 70.21% | ||
| Profit Quality | 71.02% | ||
| Current Ratio | 0.53 | ||
| Quick Ratio | 0.53 | ||
| Altman-Z | 3.52 |
F-Score6
WACC8.74%
ROIC/WACC2.67
Cap/Depr(3y)236.79%
Cap/Depr(5y)169.97%
Cap/Sales(3y)9.3%
Cap/Sales(5y)6.92%
Profit Quality(3y)77.54%
Profit Quality(5y)88.07%
High Growth Momentum
Growth
EPS 1Y (TTM)-36.45%
EPS 3Y-10.59%
EPS 5Y-3.7%
EPS Q2Q%-22.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y-1.13%
Revenue growth 5Y2.25%
Sales Q2Q%-3.38%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.79%
EBIT growth 3Y-11.19%
EBIT growth 5Y-3.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.42%
FCF growth 3Y-22.27%
FCF growth 5Y-11.96%
OCF growth 1Y-25.7%
OCF growth 3Y-9.26%
OCF growth 5Y-3.29%
NATIONAL RESEARCH CORP / NRC FAQ
What is the ChartMill fundamental rating of NATIONAL RESEARCH CORP (NRC) stock?
ChartMill assigns a fundamental rating of 4 / 10 to NRC.
What is the valuation status for NRC stock?
ChartMill assigns a valuation rating of 3 / 10 to NATIONAL RESEARCH CORP (NRC). This can be considered as Overvalued.
What is the profitability of NRC stock?
NATIONAL RESEARCH CORP (NRC) has a profitability rating of 8 / 10.
How financially healthy is NATIONAL RESEARCH CORP?
The financial health rating of NATIONAL RESEARCH CORP (NRC) is 3 / 10.
Is the dividend of NATIONAL RESEARCH CORP sustainable?
The dividend rating of NATIONAL RESEARCH CORP (NRC) is 5 / 10 and the dividend payout ratio is 67.82%.